a 2018

Possibilities of flow cytometric MRD monitoring in multiple myeloma.

KRÁLOVÁ, Romana, Renata BEZDĚKOVÁ, Markéta STEJSKALOVÁ, B. ŠEBELOVÁ, R. SUSKÁ et. al.

Basic information

Original name

Possibilities of flow cytometric MRD monitoring in multiple myeloma.

Authors

KRÁLOVÁ, Romana (203 Czech Republic, belonging to the institution), Renata BEZDĚKOVÁ (203 Czech Republic, belonging to the institution), Markéta STEJSKALOVÁ (203 Czech Republic, belonging to the institution), B. ŠEBELOVÁ, R. SUSKÁ, Miroslav PENKA (203 Czech Republic, belonging to the institution), Roman HÁJEK (203 Czech Republic, belonging to the institution) and Lucie ŘÍHOVÁ (203 Czech Republic, guarantor, belonging to the institution)

Edition

ESCCA (The European Society for Clinical Cell Analysis) 2018: At the shore of future cytometry, s. 56-57. 2018

Other information

Language

English

Type of outcome

Konferenční abstrakt

Field of Study

30204 Oncology

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

RIV identification code

RIV/00216224:14110/18:00105993

Organization unit

Faculty of Medicine

Keywords in English

MRD - multiple myeloma

Tags

International impact
Změněno: 31/1/2019 08:07, Mgr. Zuzana Jašková, Ph.D.

Abstract

V originále

Possibilities of flow cytometric minimal residual disease monitoring in multiple myeloma. Possibilities of flow cytometric minimal residual disease monitoring in multiple myeloma. Possibilities of flow cytometric minimal residual disease monitoring in multiple myeloma.

Links

MUNI/A/0968/2017, interní kód MU
Name: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit V (Acronym: VýDiTeHeMA V)
Investor: Masaryk University, Category A